Federation des caisses Desjardins du Quebec’s Acumen Pharmaceuticals ABOS Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio ABOS Stock Details ABOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,500	Closed	-$1.74K	–	2879
2025 Q2	$1.74K	Hold	1,500	–	–	﹤0.01%	2429
2025 Q1	$1.65K	Hold	1,500	–	–	﹤0.01%	2359
2024 Q4	$2.58K	Hold	1,500	–	–	﹤0.01%	2199
2024 Q3	$3.72K	Buy	+1,500	New	+$4.07K	﹤0.01%	2142
2023 Q3	–	Sell	-892	Closed	-$4.29K	–	2398
2023 Q2	$4.29K	Buy	+892	New	+$4.27K	﹤0.01%	1947

Other funds holding ABOS

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

SCV

Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KIA

Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's ABOS Position: Q3 2025 in Review

Federation des caisses Desjardins du Quebec sold out of Acumen Pharmaceuticals (ABOS) in Q3 2025, closing a stake of 1,500 shares — an estimated $1.74K sold.

Federation des caisses Desjardins du Quebec first reported a position in ABOS in Q2 2023 and held it in 5 quarters. The position peaked at $4.29K in Q2 2023. 69 funds tracked by Wall St. Rank hold ABOS as of Q3 2025.

Federation des caisses Desjardins du Quebec reported no remaining Acumen Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 1,500 Acumen Pharmaceuticals shares in Q3 2025, an estimated $1.74K.
Federation des caisses Desjardins du Quebec first reported a position in Acumen Pharmaceuticals in Q2 2023 and held it in 5 quarters.
Federation des caisses Desjardins du Quebec's Acumen Pharmaceuticals position peaked at $4.29K in Q2 2023.
69 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q3 2025.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2025, filed 14 Nov 2025.